Edward L Murphy Selected Research

Central Nervous System Diseases (CNS Diseases)

1/2021

Phenotypic and Functional Analyses Guiding Combination Immune Checkpoint Immunotherapeutic Strategies in HTLV-1 Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edward L Murphy Research Topics

Disease

16	Infections 04/2024 - 04/2003
7	Transfusion-Related Acute Lung Injury 11/2020 - 09/2009
6	HIV Infections (HIV Infection) 01/2023 - 07/2004
5	Transfusion Reaction 11/2020 - 11/2004
5	Anemia 01/2020 - 05/2012
5	Iron Deficiencies 11/2013 - 03/2011
2	Fatigue 10/2020 - 01/2019
2	Hemorrhage 01/2018 - 07/2015
2	Pulmonary Edema 01/2018 - 04/2013
2	T-Cell Leukemia (Leukemia, T Cell) 01/2012 - 09/2009
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 09/2005 - 10/2004
1	Neuroinflammatory Diseases 12/2022
1	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 12/2022
1	Hepatitis C 01/2022
1	Neglected Diseases 11/2021
1	Syphilis 08/2021
1	Breakthrough Infections 01/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2020
1	Sepsis (Septicemia) 11/2020
1	Hepatitis B 11/2019
1	Hemolysis 01/2019
1	Hematologic Diseases (Blood Diseases) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Acute Kidney Injury (Acute Renal Failure) 01/2018
1	Inflammation (Inflammations) 08/2015
1	Shock 02/2012
1	Alcoholism (Alcohol Abuse) 02/2012
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2012
1	Chronic Hepatitis C 07/2010
1	Leukemia 09/2009
1	Lymphocytosis 09/2009
1	West Nile Fever 02/2009
1	Coinfection 05/2007
1	Viremia 03/2006
1	HTLV-II Infections 04/2005

Drug/Important Bio-Agent (IBA)

6	Nucleic AcidsIBA 07/2010 - 04/2003
5	N-acetyltalosaminuronic acid (NAT)IBA 04/2024 - 11/2004
5	IronIBA 01/2019 - 03/2011
5	Hemoglobins (Hemoglobin)IBA 01/2019 - 05/2012
4	VaccinesIBA 01/2022 - 04/2005
3	Ferritins (Ferritin)IBA 01/2019 - 03/2011
3	Interleukin-8 (Interleukin 8)IBA 08/2015 - 02/2012
3	AntibodiesIBA 10/2012 - 09/2009
2	AntigensIBA 04/2024 - 04/2014
2	CytokinesIBA 12/2022 - 08/2015
2	RNA (Ribonucleic Acid)IBA 10/2022 - 03/2006
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 08/2021 - 11/2019
2	Interferon LambdaIBA 12/2020 - 11/2020
2	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 05/2007
2	hydroxide ionIBA 01/2018 - 07/2015
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 08/2015
2	Interleukin-10 (Interleukin 10)IBA 08/2015 - 07/2014
2	Messenger RNA (mRNA)IBA 01/2012 - 05/2007
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 09/2009
2	HLA Antigens (Human Leukocyte Antigens)IBA 10/2011 - 09/2009
1	ABO Blood-Group SystemIBA 01/2023
1	Blood Group Antigens (Blood Groups)IBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022
1	Amino Acids FDA Link 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	LigandsIBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 11/2020
1	Pyridinolcarbamate (P23)IBA 11/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2020
1	Viral DNAIBA 11/2019
1	DiureticsIBA 01/2018
1	EpitopesIBA 01/2018
1	ORALIT (ORS)IBA 01/2018
1	N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA 01/2017
1	Natriuretic PeptidesIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 08/2015
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2014
1	Cocaine (Cocaine HCl)IBA 05/2006
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 04/2005
1	Polysaccharides (Glycans)IBA 04/2005

Therapy/Procedure

7	Blood Transfusion (Blood Transfusions) 01/2020 - 08/2004
3	Therapeutics 12/2022 - 07/2004
3	Erythrocyte Transfusion 01/2021 - 01/2019
2	Artificial Respiration (Mechanical Ventilation) 01/2018 - 07/2014
2	Tattooing 01/2012 - 10/2004
2	Donor Selection 10/2011 - 07/2010
1	Art Therapy 10/2022
1	Patient Readmission 01/2019
1	Prenatal Care (Care, Prenatal) 01/2018
1	Critical Care (Surgical Intensive Care) 01/2018
1	Blood Component Removal (Apheresis) 06/2011
1	Highly Active Antiretroviral Therapy (HAART) 05/2007